RNTX
Rein Therapeutics Inc
0.7947$
+0.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
Rein Therapeutics Inc (RNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -15 | -21 | -28 | -26 | -20 | -24 | -25 | -20 | -22 | -19 | |
| 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | |
| 0.6 | 0.7 | 1.7 | 3.3 | 2.1 | 1.9 | 2.3 | 2.1 | 1.2 | 1.1 | 2.2 | |
| 0.2 | 0.7 | 0.3 | 0.4 | 0.9 | -1.3 | 0.2 | 0.4 | -5.4 | 2.4 | -0.9 | |
| 0.1 | 0.0 | 0.1 | 4.4 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 11 | 0.0 | -39 | 25 | -2.8 | 6.4 | -36 | 26 | 16 | – | – | |
| -0.1 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.0 | – | – | – | – | |
| -1.4 | 32 | 51 | 2.5 | 24 | 16 | 56 | 0.0 | 16 | 18 | 9.8 | |
| -2.4 | 17 | -8.9 | -0.7 | -5.3 | 1.7 | -4.0 | 1.6 | 12 | -4.5 | -9.7 | |
| -12 | -15 | -21 | -32 | -27 | -20 | -24 | -25 | -20 | -22 | -19 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.